| Q33883440 | A novel strategy to screen Bacillus Calmette-Guérin protein antigen recognized by γδ TCR |
| Q34104924 | A role for epithelial gamma delta T cells in tissue repair |
| Q44016587 | Accumulation of a potent gammadelta T-cell stimulator after deletion of the lytB gene in Escherichia coli |
| Q73968941 | Activation of human Vgamma9Vdelta2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells |
| Q40146526 | Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model |
| Q51145613 | Alteration of Mevalonate Pathway in Rat Splenic Lymphocytes: Possible Role in Cytokines Secretion Regulated by L-Theanine. |
| Q36759195 | Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate |
| Q90430104 | Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor |
| Q28363497 | Antibacterial effect of human V gamma 2V delta 2 T cells in vivo |
| Q28140355 | Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system |
| Q24675038 | Antigens in tea-beverage prime human Vγ2Vδ2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses |
| Q28660812 | Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells |
| Q24792697 | Circulating gammadelta T cells in young/adult and old patients with cutaneous primary melanoma |
| Q34154610 | Clonal immune responses of Mycobacterium-specific γδ T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection |
| Q98465659 | Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells |
| Q37127038 | Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid. |
| Q33505805 | Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells |
| Q38217512 | Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? |
| Q37344573 | Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. |
| Q90259222 | Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire |
| Q42689489 | Differential TCR gene usage between WC1- and WC1+ ruminant gammadelta T cell subpopulations including those responding to bacterial antigen |
| Q35587132 | Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma. |
| Q33514867 | Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells |
| Q59350350 | Expansion and Adoptive Transfer of Human Vδ2 T Cells to Assess Antitumor Effects In Vivo |
| Q39571159 | Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination |
| Q47666620 | Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
| Q41941339 | Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections |
| Q36376704 | Functional inactivation in the whole population of human V gamma 9/V delta 2 T lymphocytes induced by a nonpeptidic antagonist |
| Q37587832 | Gammadelta T cells as immune effectors against high-grade gliomas |
| Q35794616 | Gammadelta T cells play an essential role in several forms of tolerance |
| Q33455830 | Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells |
| Q39639684 | Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways. |
| Q36908780 | Human gamma delta T cells: candidates for the development of immunotherapeutic strategies |
| Q36366439 | Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin |
| Q33904052 | Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection |
| Q48085513 | Identification of three new bovine T-cell receptor delta variable gene subgroups expressed by peripheral blood T cells |
| Q36672600 | Immune biology of Ag-specific γδ T cells in infections |
| Q36422152 | Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection |
| Q34965681 | Immunogenic and antioxidant effects of a pathogen-associated prenyl pyrophosphate in Anopheles gambiae |
| Q39397758 | Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins |
| Q55311835 | Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer. |
| Q28360441 | In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors |
| Q35889808 | Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism |
| Q47346919 | Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells |
| Q24309154 | Linking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretion |
| Q34819275 | Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells |
| Q36875504 | Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections |
| Q36528792 | NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal Vγ2Vδ2 T-cell expansion |
| Q90534741 | New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity |
| Q39699806 | Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load |
| Q34127581 | Phosphoantigen presentation by macrophages to mycobacterium tuberculosis--reactive Vgamma9Vdelta2+ T cells: modulation by chloroquine. |
| Q24645473 | Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity |
| Q37226687 | Photoaffinity antigens for human gammadelta T cells |
| Q33832188 | Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques |
| Q38890450 | Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy. |
| Q41084348 | Recognition of nonpeptide antigens by T cells |
| Q44898932 | Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin |
| Q37731978 | Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells |
| Q90521943 | Revisiting the Interaction of γδ T-Cells and B-Cells |
| Q41710708 | Role of gamma delta T cells in immunity to infectious diseases and the regulation of hematolymphoid cell development |
| Q36368376 | Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity |
| Q35000371 | Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells. |
| Q36845046 | Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells |
| Q39807695 | Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen. |
| Q64264790 | Suppression of R5-type of HIV-1 in CD4+ NKT cells by Vδ1+ T cells activated by flavonoid glycosides, hesperidin and linarin |
| Q62735455 | Synthesis and Immunomodulatory Activity of Fluorine-Containing Bisphosphonates |
| Q27682926 | The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells |
| Q27670973 | The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies |
| Q36491653 | The anti-tumour effects of zoledronic acid |
| Q42086300 | Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors |
| Q37168337 | Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity |
| Q34749889 | Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs |
| Q24797447 | Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease |
| Q36803818 | Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells |
| Q34104934 | gamma delta cells in gut infection, immunopathology, and organogenesis. |
| Q37689811 | gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? |
| Q37836561 | γδ T cell receptor ligands and modes of antigen recognition |